The document also adds that the proposed changes by the WHO could give people the wrong idea, leading them to think that the current Schedule IV stance impedes research and that the international framework isn’t compatible with research. What they’re basically saying is that even if the United States acknowledges the benefits of reclassifying cannabis, the government is worried about how it would turn out.
New Jersey’s THC beverage market is heading into the most consequential stretch of its short…
Mormon Wives star Mikayla Matthews says medical cannabis was “literally life-changing” for her nerve pain…
Chains reorder every two weeks and earn twice the discounts. Independents stock the same breadth…
We head to Canna Country Farms in Humboldt for Legendary Strains to discover the Ocimene…
Cannabis advocates should take the lesson here too. The industry doesn't need to inflate its…
Twenty patient associations from across northeastern Brazil are meeting in Fortaleza this month, inside a…